Valuation: IRADIMED CORPORATION

Market Cap 1.11B 999M 923M 835M 1.58B 104B 1.62B 11.05B 4.41B 55.71B 4.16B 4.07B 177B P/E 2026 *
45.3x
P/E 2027 * 38.8x
Enterprise Value 1.11B 999M 923M 835M 1.58B 104B 1.62B 11.05B 4.41B 55.71B 4.16B 4.07B 177B EV / Sales 2026 *
12x
EV / Sales 2027 * 10.8x
Free-Float
64.82%
Yield 2026 *
-
Yield 2027 * -
1 day-0.16%
1 week+6.74%
Current month+12.91%
1 month-0.99%
3 months-4.09%
6 months+0.34%
Current year-11.00%
1 week 83.31
Extreme 83.31
89.45
1 month 76.35
Extreme 76.35
91.05
Current year 76.35
Extreme 76.35
107.9
1 year 76.35
Extreme 76.35
107.9
3 years 39.24
Extreme 39.24
107.9
5 years 26
Extreme 26
107.9
10 years 7.85
Extreme 7.85
107.9
Manager TitleAgeSince
Chief Executive Officer 72 28/05/2020
Director of Finance/CFO 64 20/06/2022
Chief Tech/Sci/R&D Officer - 01/01/2020
Director TitleAgeSince
Director/Board Member 73 01/01/2014
Director/Board Member 61 02/09/2025
Director/Board Member 70 01/01/2019
Date Insider Type Main position Quantity % Market Cap. Importance
23/09/26 Exercice

Director

1,396 0.0109%
03/09/26 Sell

Director

-1,419 0.0111%
04/06/26 Sell

Director

-3,000 0.0235%
Change 5-day change 1-year change 3-year change Capi.($)
-0.16%+6.74%+0.59%+118.80% 1.11B
-0.07%+2.77%+24.53%+60.05% 266B
-0.34%+2.26%+11.43%+19.45% 166B
-0.11%+1.99%-21.98%+62.00% 156B
+0.96%+3.75%-55.28%-12.47% 64.79B
+1.73%+11.16%+25.84%+64.79% 59.81B
+1.35%+0.39%+0.37%-8.59% 53.3B
-0.52%+0.85%+20.90%+63.13% 50.15B
-0.26%+0.51%+3.05%+84.62% 49.47B
-0.97%+2.39%+25.05%+84.00% 46.72B
Average -0.11%+3.46%+3.45%+53.58% 91B
Weighted average by Cap. -0.17%+3.00%+5.86%+46.96%

Financials

2026 *2027 *
Net sales 92.2M 83.09M 76.74M 69.42M 131M 8.64B 135M 919M 366M 4.63B 346M 339M 14.72B 102M 92.22M 85.17M 77.05M 146M 9.59B 150M 1.02B 407M 5.14B 384M 376M 16.34B
Net income 24.57M 22.14M 20.45M 18.5M 35M 2.3B 35.89M 245M 97.61M 1.23B 92.19M 90.22M 3.92B 28.8M 25.95M 23.97M 21.69M 41.03M 2.7B 42.08M 287M 114M 1.45B 108M 106M 4.6B
Net Debt - -
Projected Income Statement - Annual - IRADIMED CORPORATION
Logo IRADIMED CORPORATION
IRadimed Corporation develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and accessories, disposables and services. Its MRidium 3870 MRI Compatible IV infusion pump system provides a non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium 3860+ MRI Compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to safely and predictably and other IV fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to safely and accurately during various MRI procedures. The Company sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably on magnetic fields of over 30,000 gauss.
Employees
166
Date Price Change Volume
11/11/26 $86.50 -0.25% 76,514
10/11/26 $86.72 -0.25% 129,206
09/11/26 $86.94 +0.73% 102,586
06/11/26 $86.31 +0.90% 222,103
05/11/26 $85.54 -3.43% 128,002
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
B
MarketScreener Ratings - IRADIMED CORPORATION
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
86.72USD
Average target price
118.00USD
Spread / Average Target
+36.07%
  1. Stock Market
  2. Stocks
  3. IRMD Stock